New England Biolabs
Business Services · Massachusetts, United States · 650 Employees
Founded in 1974, New England BioLabs is a privately held company that produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology, and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Polbase. The company is headquartered in Ipswitch, Massachusetts.Read More
Who is New England Biolabs
Headquarters
240 County Rd, Ipswich, Massachusetts, 01938, United States
Phone Number
(978) 927-5054
Website
Revenue
$137.4M
Industry
New England Biolabs's Social Media
Popular Searches
New England Biolabs
New England Biolabs Inc
New England Biolabs GmbH
New England Biolabs Ltd
New England Biolabs Pty Ltd
Top Competitors of New England Biolabs
New England Biolabs Org Chart
Phone
Email
New England Biolabs Company Metrics
Acquisitions & Subsidiaries
Jul 18, 2022
Nebsticktogether
Jul 18, 2022
New England Biolabs Foundation
Jul 18, 2022
Monarchfeedback
Jul 18, 2022
Nebmonarchpackaging
Apr 11, 2012
Fluorogenics
New England Biolabs
See More Acquisitions & Subsidiaries
New England Biolabs Tech Stack
New England Biolabs News & Media
Ultima Genomics Partners with New England Biolabs® to Expand Research Applications on Ultima Sequencers
NEWARK, Calif., Feb. 6, 2023 /PRNewswire/ -- Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput sequencing architecture, today announced a collaboration to develop and enable use of New England Biolabs' (NEB®) NEBNext® reagents and library preparation kits on...
Feb 6, 2023
New England Biolabs® Introduces NEB Lyophilization Sciences™, Ltd.
Combining enzymology and lyophilization expertise for best-in-class solutions for in vitro diagnostics IPSWICH, Mass., Dec. 1, 2022 /PRNewswire/ -- New England Biolabs (NEB®), a leading supplier of life science reagents, introduces New England Biolabs Lyophilization Sciences (NEB Lyo...Dec 1, 2022
New England Biolabs® Introduces Faustovirus Capping Enzyme, a Novel Enzymatic mRNA Capping Solution for mRNA Manufacturing
New enzyme improves capping efficiency and scalability for mRNA manufacturing workflows, including vaccine generation IPSWICH, Mass., Aug. 9, 2022 /PRNewswire/ -- Today, New England Biolabs (NEB®) announces the release of the Faustovirus Capping Enzyme (FCE), an mRNA capping solution that...Aug 9, 2022
Ellard steps down as Biolabs CEO - Ipswich Local News
Jim Ellard, longtime CEO of New England Biolabs based in Ipswich MA, accounces his retirement. Sal Russello to take over.Jul 8, 2022
New England Biolabs® Chief Executive Officer Announces Retirement
Jim Ellard stepping down after nearly two decades of growth and scientific advancement IPSWICH, Mass., July 7, 2022 /PRNewswire/ -- New England Biolabs (NEB®), a pioneer in the field of molecular biology and global supplier of reagents to the life science industry, today announced that...Jul 7, 2022Read more news
Frequently Asked Questions regarding New England Biolabs
Founded in 1974, New England BioLabs is a privately held company that produces and supplies recombinant and native enzyme reagents for the life science research, as well as providing solutions supporting genome editing, synthetic biology, and next-generation sequencing. NEB also provides free access to research tools such as REBASE, InBASE, and Pol... Read More
100/100
Slide to rate Salvatore Russello as a Chief Executive Officer
Trending Intent Signals Intent topics are topics that prospects are actively searching for online.
Find out what New England Biolabs is actively searching across the web.
Topic
Signal Score
Signal Score indicates how big the spike is compared to a company's historical baseline for consuming content.Managed Service Provider
100
3 Signals found
Signal Location
Asia
Date
2/8/23
Score
Audience
Enterprise Resource Planning
74
5 Signals found
Signal Location
Africa
Date
2/8/23
Score
Audience
4.4/5 on G2 Crowd
Test Drive ZoomInfo's Directories
Browse Directories
